A polyphosphonate (PDPA) flame retardant that contains phenyl phosphonic dichloride and 9,10-dihydro-9-oxa-10-phosphaphenanthrene-10-oxide groups, has been synthesized. The flame retardant was introduced into epoxy resins (EP) and cured by 4,4’-diamino diphenylmethane. The vertical burning, limited-oxygen index and cone calorimeter tests reveal that the PDPA can enhance the flame-retardant properties of the EP significantly. With only a 4 wt% PDPA loading, the EP composites achieved a limited-oxygen index value of 33.4% and a V-0 rating in the vertical burning test, and the peak heat release rate and total heat release were decreased by 40.9% and 24.6%, respectively. The thermal properties and gas pyrolysis products of the EP composites were evaluated by thermogravimetric analysis and thermogravimetric analysis-Fourier transform infrared spectroscopy, and the morphology and structure of residual char were characterized by scanning electron microscopy, Flourier transform infrared spectroscopy and X-ray photoelectron spectroscopy. To explain the combined effects of the condensed and gas phases, modes of the flame-retardant action are proposed.
Ni Ding,Gangjian Luo,Huiting Li,Chengyuan Xing,Yuanji Gao,Wenjie Xi,Weijie Wu,Dan Wang,Lei Zheng,Yang Kang,Xinjin Chi
The mortality rate of sepsis remains high despite improvements in the diagnosis and treatment of sepsis using symptomatic and supportive therapies, such as anti-infection therapy and fluid resuscitation. Nucleic acid-based drugs have therapeutic potential, although their poor stability and low delivery efficiency have hindered their widespread use. Herein, it is confirmed that miR-223 can polarize proinflammation M1 macrophages to anti-inflammation M2 macrophages. A pH-sensitive nano-drug delivery system comprising β-cyclodextrin-poly(2-(diisopropylamino)ethyl methacrylate)/distearoyl phosphoethanolamine-polyethylene glycol (β-CD-PDPA/DSPE-PEG) is synthesized and developed to target M1 macrophages and miR-223 is encapsulated into nanoparticles (NPs) for sepsis treatment. NPs/miR-223 demonstrated in vitro pH responsiveness with favorable biosafety, stability, and high delivery efficiency. In vivo studies demonstrate that NPs/miR-223 are preferentially accumulated and retained in the inflammation site, thereby reducing inflammation and improving the survival rate of mice with sepsis while exhibiting ideal biosafety. Mechanically, NPs/miR-223 regulates macrophage polarization by targeting Pknox1 and inhibiting the activation of the NF-κB signaling pathway, thereby achieving an anti-inflammatory effect. Collectively, it is demonstrated that the miRNA delivery vector described here provides a new approach for sepsis treatment and accelerates the advancement of nucleic acid drug therapy.
危险品化学品经营许可证（带存储）